Supplementary Materials

• Supplementary Table 1: Ovarian tumor tissue sources
• Supplementary Table 2: Properties of ovarian cancer-specific alternative splicing (AS) variants
• Supplementary Figure 1: Layered and integrated system for splicing annotation (LISA)
• Supplementary Figure 2: Alternative splicing annotations generated by the LISA
• Supplementary Figure 3: Individual splicing distribution graphs for 64 ASEs tested in 25 normal and 21 cancer tissues
• Supplementary Figure 4: Quantitative PCR for a sample of 11 validated genes in 2 ovarian normal and 2 serous tumor pools
• Legends